Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK gD2t Vaccine Safety in HSV Seropositive or Seronegative Subjects
NCT00698568Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 1996
- Primary completion
- Apr 1999
- Countries
- 12
01
Overview
A Phase 3 trial of Simplirix in herpes simplex virus infection, sponsored by GSK. Started Oct 1996; status: completed.
02
Drugs
Simplirix
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00698568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698568.